Pericardiocentesis versus window formation in malignant pericardial effusion: trends and outcomes

• Published in: Heart (British Cardiac Society) Vol. 110; no. 12; p. 863
• Main Authors: Lee, Jaeoh, Kim, Kyu, Gwak, Seo-Yeon, Lee, Hyun-Jung, Cho, Iksung, Hong, Geu-Ru, Ha, Jong-Won, Shim, Chi Young
• Format: Journal Article
• Language: English
• Published: England 01-06-2024
• Subjects: Aged; Drainage - methods; Female; Humans; Male; Middle Aged; Neoplasms - complications; Pericardial Effusion - epidemiology; Pericardial Effusion - etiology; Pericardial Effusion - therapy; Pericardial Window Techniques; Pericardiocentesis - methods; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Cardiac Tamponade; Pericardial Effusion; Cardiac Surgical Procedures
• ISSN: 1468-201X
• DOI: 10.1136/heartjnl-2023-323542

Malignant pericardial effusion (MPE) in patients with cancer is associated with poor prognosis. This study aimed to compare clinical outcomes in patients with cancer who underwent pericardiocentesis versus pericardial window formation.
In the present study, 765 consecutive patients with cancer (mean age 58.4 years, 395 men) who underwent pericardial drainage between 2003 and 2022 were retrospectively analysed. All-cause death and MPE recurrence were compared based on the drainage method (pericardiocentesis vs pericardial window formation) and time period (period 1: 2003-2012; period 2: 2013-2022).
Pericardiocentesis was performed in 639 (83.5%) patients and pericardial window formation in 126 (16.5%). There was no difference in age, sex distribution, proportion of metastatic or relapsed cancer, and chemotherapy status between the pericardiocentesis and pericardial window formation groups. Difference was not found in all-cause death between the two groups (log-rank p=0.226) regardless of the period. The pericardial window formation group was associated with lower MPE recurrence than the pericardiocentesis group (6.3% vs 18.0%, log-rank p=0.001). This advantage of pericardial window formation was more significant in period 2 (18.1%
1.3%, log-rank p=0.005). In multivariate analysis, pericardial window formation was associated with lower MPE recurrence (HR: 0.31, 95% CI: 0.15 to 0.63, p=0.001); younger age, metastatic or relapsed cancer, and positive malignant cells in pericardial fluid were associated with increased recurrence.
In patients undergoing pericardial drainage for MPE, pericardial window formation showed mortality outcomes comparable with pericardiocentesis and was associated with lower incidence of MPE recurrence.